NASDAQ:IMRA IMARA (IMRA) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$6.32▼$25.2852-Week Range N/AVolume271,700 shsAverage Volume138,364 shsMarket Capitalization$165.80 millionP/E Ratio126.40Dividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get IMARA alerts: Email Address Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About IMARA Stock (NASDAQ:IMRA)IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.Read More Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE IMRA Stock News HeadlinesMay 11, 2024 | msn.comImran Khan opens up on his comparisons to Ranbir Kapoor: 'I never considered...'August 23, 2023 | health.usnews.comImara BlumeJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.March 3, 2023 | finance.yahoo.comIMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo FinanceFebruary 22, 2023 | finance.yahoo.comImara Announces Stockholder Approval of Merger With EnlivenJanuary 5, 2023 | benzinga.comSHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing InvestigationsOctober 25, 2022 | benzinga.comImara 10% Owner Trades $336K In Company StockOctober 20, 2022 | benzinga.com$1.9 Million Bet On This Biotechnology Stock? Check Out These 4 Penny Stocks Insiders Are Buying - Imara - BenzingaJuly 26, 2024 | American Hartford Gold Group (Ad)Dave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.October 18, 2022 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of IMARA Inc. - IMRA - PR NewswireOctober 18, 2022 | prnewswire.comSTOCKHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of IMARA Inc. - IMRAOctober 17, 2022 | streetinsider.comAHF to Protest CIGNA for Shortchanging Pharmacies: 'Cigna Doesn't Care!' - StreetInsider.comOctober 17, 2022 | bloomberg.comZimbabwe's Currency Crackdown Spurs Wider Use of US Dollars - BloombergOctober 17, 2022 | bizjournals.comStruggling blood disorder biotech Imara shuts down via reverse merger - Boston Business Journal - The Business JournalsOctober 17, 2022 | benzinga.com12 Health Care Stocks Moving In Monday's Pre-Market Session - Applied DNA Sciences (NASDAQ:APDN), Acorda - BenzingaOctober 16, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, FCRD, IMRA - Imara (NASDAQ:IMRA), First Ea - BenzingaOctober 15, 2022 | benzinga.comLifshitz Law PLLC Announces Investigations of OIIM, JVA, SLDB, and IMRA - Imara (NASDAQ:IMRA), Coffee Hol - BenzingaOctober 15, 2022 | benzinga.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LOGC, IMRA, SBTX - Imara (NASDAQ:IMRA), LogicBio - BenzingaSee More Headlines Receive IMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/09/2021Today7/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMRA CUSIPN/A CIK1672619 Webwww.imaratx.com PhoneN/AFaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.05 Trailing P/E Ratio126.40 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.49 million Net MarginsN/A Pretax MarginN/A Return on Equity2.12% Return on Assets2.00% Debt Debt-to-Equity RatioN/A Current Ratio48.98 Quick Ratio48.98 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash Flow75.24 Book Value$3.44 per share Price / BookN/AMiscellaneous Outstanding Shares26,234,000Free Float16,449,000Market Cap$165.80 million OptionableNot Optionable Beta1.09 10 "Recession Proof" Stocks That Will Thrive in Any MarketWhich stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.Get This Free Report Key ExecutivesDr. Rahul D. Ballal Ph.D. (Age 44)Pres, CEO & Director Comp: $761.55kMr. Michael P. Gray MBA (Age 51)CPA, CFO & COO Comp: $641.24kMr. Stephen M. Migausky J.D.Sr. VP of Legal & Gen. CounselKey Competitorsbluebird bioNASDAQ:BLUEEditas MedicineNASDAQ:EDITEmergent BioSolutionsNYSE:EBSSilence TherapeuticsNASDAQ:SLNKalVista PharmaceuticalsNASDAQ:KALVView All Competitors IMRA Stock Analysis - Frequently Asked Questions How were IMARA's earnings last quarter? IMARA Inc. (NASDAQ:IMRA) posted its quarterly earnings results on Tuesday, November, 9th. The company reported ($2.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.64) by $1.44. When did IMARA's stock split? IMARA shares reverse split before market open on Friday, February 24th 2023. The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did IMARA IPO? IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink acted as the underwriters for the IPO. What other stocks do shareholders of IMARA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include Novavax (NVAX), Axsome Therapeutics (AXSM), OPKO Health (OPK), BioXcel Therapeutics (BTAI), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY) and Dynavax Technologies (DVAX). This page (NASDAQ:IMRA) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMARA Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMARA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.